Filing Details

Accession Number:
0001104659-16-139260
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-12 12:49:37
Reporting Period:
2016-08-10
Filing Date:
2016-08-12
Accepted Time:
2016-08-12 12:49:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1638287 Gemphire Therapeutics Inc. GEMP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296853 S Jeffrey Mathiesen 43334 Seven Mile Road
Suite 1000
Northville MI 48167
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-10 3,927 $6.71 3,927 No 4 C Direct
Common Stock Acquisiton 2016-08-10 4,000 $10.00 7,927 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 8% Convertible Subordinated Promissory Note Disposition 2016-08-10 0 $0.00 3,927 $6.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. The note was issued in the original principal amount of $25,000. The outstanding principal and $1,337 of accrued interest on the note automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering.